Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis
Purpose Idiopathic pulmonary fibrosis (IPF) produces symptoms and activity limitations that impair health-related quality of life (HRQOL). The Patient-Reported Outcomes Measurement Information System ® (PROMIS ® ) includes measures of self-reported health and HRQOL for a range of conditions. This st...
Gespeichert in:
| Veröffentlicht in: | Lung 2016-04, Vol.194 (2), p.227-234 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 234 |
|---|---|
| container_issue | 2 |
| container_start_page | 227 |
| container_title | Lung |
| container_volume | 194 |
| creator | Yount, Susan E. Beaumont, Jennifer L. Chen, Shih-Yin Kaiser, Karen Wortman, Katy Van Brunt, David L. Swigris, Jeffrey Cella, David |
| description | Purpose
Idiopathic pulmonary fibrosis (IPF) produces symptoms and activity limitations that impair health-related quality of life (HRQOL). The Patient-Reported Outcomes Measurement Information System
®
(PROMIS
®
) includes measures of self-reported health and HRQOL for a range of conditions. This study evaluated the HRQOL of individuals with IPF using PROMIS measures and examined associations between HRQOL and key symptoms or supplemental oxygen need.
Methods
Individuals who reported being told by a doctor that they have IPF completed an online battery of measures at baseline and 7–10 days later (for test–retest reliability). Measures included a brief survey of demographic and health-related questions, the PROMIS-29 profile, the Modified Medical Research Council Dyspnea Scale (MMRC), PROMIS dyspnea severity short form, A Tool to Assess Quality of life in IPF (ATAQ-IPF) and one cough item from the Functional Assessment of Chronic Illness Therapy (FACIT).
Results
220 individuals were included in the final sample. Except for sleep disturbance, all PROMIS domain scores significantly (
p
|
| doi_str_mv | 10.1007/s00408-016-9850-y |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1774532968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A446755796</galeid><sourcerecordid>A446755796</sourcerecordid><originalsourceid>FETCH-LOGICAL-c578t-c297fdd0a7ad283bf3150e0eeb746722034e997f40e16a6e6699ce7a0efcb1003</originalsourceid><addsrcrecordid>eNp1klFrFDEUhYModlv9Ab7IgCB9SU0yk2TmsRRrCytW0eeQydzspmSSdZKh7L83263aykoeAsl3LufeexB6Q8kZJUR-SIQ0pMWECty1nODtM7SgTc0wlZw8RwtSNxSzwhyh45RuCaFSUP4SHTHRCtq2fIE-X4H2eY2_gdcZhurrrL3L2yraauksVC5UNzo7CDlVdy6vq-vBxY3Oa2eqm9mPMehpW126forJpVfohdU-weuH-wT9uPz4_eIKL798ur44X2LDZZuxYZ20w0C01ANr697WlBMgAL1shGSs-IauIA0BKrQAIbrOgNQErOlL5_UJOt3X3Uzx5wwpq9ElA97rAHFOikrZ8Jp1oi3ou3_Q2zhPobi7p4oTyvhfaqU9KBdszJM2u6LqvCmeOJedKBQ-QK0gwKR9DGBdeX7Cnx3gyxlgdOag4P0jwfp-NSn6ObsY0lOQ7kFT5p4msGozubGsQlGidtlQ-2yokg21y4baFs3bh0nM_QjDH8XvMBSA7YFUvsIKpkej-m_VX_U4wPA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1774297125</pqid></control><display><type>article</type><title>Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Yount, Susan E. ; Beaumont, Jennifer L. ; Chen, Shih-Yin ; Kaiser, Karen ; Wortman, Katy ; Van Brunt, David L. ; Swigris, Jeffrey ; Cella, David</creator><creatorcontrib>Yount, Susan E. ; Beaumont, Jennifer L. ; Chen, Shih-Yin ; Kaiser, Karen ; Wortman, Katy ; Van Brunt, David L. ; Swigris, Jeffrey ; Cella, David</creatorcontrib><description>Purpose
Idiopathic pulmonary fibrosis (IPF) produces symptoms and activity limitations that impair health-related quality of life (HRQOL). The Patient-Reported Outcomes Measurement Information System
®
(PROMIS
®
) includes measures of self-reported health and HRQOL for a range of conditions. This study evaluated the HRQOL of individuals with IPF using PROMIS measures and examined associations between HRQOL and key symptoms or supplemental oxygen need.
Methods
Individuals who reported being told by a doctor that they have IPF completed an online battery of measures at baseline and 7–10 days later (for test–retest reliability). Measures included a brief survey of demographic and health-related questions, the PROMIS-29 profile, the Modified Medical Research Council Dyspnea Scale (MMRC), PROMIS dyspnea severity short form, A Tool to Assess Quality of life in IPF (ATAQ-IPF) and one cough item from the Functional Assessment of Chronic Illness Therapy (FACIT).
Results
220 individuals were included in the final sample. Except for sleep disturbance, all PROMIS domain scores significantly (
p
< .01) differed by MMRC level. Supplemental oxygen users were more impaired than non-users in fatigue, physical function, and social role participation (
p
< 0.01). The test–retest reliability was acceptable to excellent (>0.7) for all scales, but was lower for sleep disturbance (0.64).
Conclusions
People with IPF report substantial deficits in HRQOL across a range of PROMIS domains, and deficits vary by dyspnea and cough severity. These deficits warrant monitoring in clinical practice and consideration when investigating new therapies. Further research is required to further evaluate the psychometric performance of the PROMIS-29 in IPF.</description><identifier>ISSN: 0341-2040</identifier><identifier>EISSN: 1432-1750</identifier><identifier>DOI: 10.1007/s00408-016-9850-y</identifier><identifier>PMID: 26861885</identifier><identifier>CODEN: LUNGD9</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Aged ; Aged, 80 and over ; Care and treatment ; Cost of Illness ; Cough - diagnosis ; Cough - physiopathology ; Cough - psychology ; Demographics ; Development and progression ; Dyspnea - diagnosis ; Dyspnea - physiopathology ; Dyspnea - psychology ; Fatigue - diagnosis ; Fatigue - physiopathology ; Fatigue - psychology ; Female ; Health ; Health Status ; Humans ; Idiopathic Pulmonary Fibrosis - diagnosis ; Idiopathic Pulmonary Fibrosis - physiopathology ; Idiopathic Pulmonary Fibrosis - psychology ; Idiopathic Pulmonary Fibrosis - therapy ; Male ; Medicine ; Medicine & Public Health ; Mental Health ; Middle Aged ; Oxygen Inhalation Therapy ; Patient Reported Outcome Measures ; Pneumology/Respiratory System ; Pulmonary fibrosis ; Quality of Life ; Severity of Illness Index ; Social Participation ; Therapy ; Time Factors</subject><ispartof>Lung, 2016-04, Vol.194 (2), p.227-234</ispartof><rights>Springer Science+Business Media New York 2016</rights><rights>COPYRIGHT 2016 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c578t-c297fdd0a7ad283bf3150e0eeb746722034e997f40e16a6e6699ce7a0efcb1003</citedby><cites>FETCH-LOGICAL-c578t-c297fdd0a7ad283bf3150e0eeb746722034e997f40e16a6e6699ce7a0efcb1003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00408-016-9850-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00408-016-9850-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26861885$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yount, Susan E.</creatorcontrib><creatorcontrib>Beaumont, Jennifer L.</creatorcontrib><creatorcontrib>Chen, Shih-Yin</creatorcontrib><creatorcontrib>Kaiser, Karen</creatorcontrib><creatorcontrib>Wortman, Katy</creatorcontrib><creatorcontrib>Van Brunt, David L.</creatorcontrib><creatorcontrib>Swigris, Jeffrey</creatorcontrib><creatorcontrib>Cella, David</creatorcontrib><title>Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis</title><title>Lung</title><addtitle>Lung</addtitle><addtitle>Lung</addtitle><description>Purpose
Idiopathic pulmonary fibrosis (IPF) produces symptoms and activity limitations that impair health-related quality of life (HRQOL). The Patient-Reported Outcomes Measurement Information System
®
(PROMIS
®
) includes measures of self-reported health and HRQOL for a range of conditions. This study evaluated the HRQOL of individuals with IPF using PROMIS measures and examined associations between HRQOL and key symptoms or supplemental oxygen need.
Methods
Individuals who reported being told by a doctor that they have IPF completed an online battery of measures at baseline and 7–10 days later (for test–retest reliability). Measures included a brief survey of demographic and health-related questions, the PROMIS-29 profile, the Modified Medical Research Council Dyspnea Scale (MMRC), PROMIS dyspnea severity short form, A Tool to Assess Quality of life in IPF (ATAQ-IPF) and one cough item from the Functional Assessment of Chronic Illness Therapy (FACIT).
Results
220 individuals were included in the final sample. Except for sleep disturbance, all PROMIS domain scores significantly (
p
< .01) differed by MMRC level. Supplemental oxygen users were more impaired than non-users in fatigue, physical function, and social role participation (
p
< 0.01). The test–retest reliability was acceptable to excellent (>0.7) for all scales, but was lower for sleep disturbance (0.64).
Conclusions
People with IPF report substantial deficits in HRQOL across a range of PROMIS domains, and deficits vary by dyspnea and cough severity. These deficits warrant monitoring in clinical practice and consideration when investigating new therapies. Further research is required to further evaluate the psychometric performance of the PROMIS-29 in IPF.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Care and treatment</subject><subject>Cost of Illness</subject><subject>Cough - diagnosis</subject><subject>Cough - physiopathology</subject><subject>Cough - psychology</subject><subject>Demographics</subject><subject>Development and progression</subject><subject>Dyspnea - diagnosis</subject><subject>Dyspnea - physiopathology</subject><subject>Dyspnea - psychology</subject><subject>Fatigue - diagnosis</subject><subject>Fatigue - physiopathology</subject><subject>Fatigue - psychology</subject><subject>Female</subject><subject>Health</subject><subject>Health Status</subject><subject>Humans</subject><subject>Idiopathic Pulmonary Fibrosis - diagnosis</subject><subject>Idiopathic Pulmonary Fibrosis - physiopathology</subject><subject>Idiopathic Pulmonary Fibrosis - psychology</subject><subject>Idiopathic Pulmonary Fibrosis - therapy</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Mental Health</subject><subject>Middle Aged</subject><subject>Oxygen Inhalation Therapy</subject><subject>Patient Reported Outcome Measures</subject><subject>Pneumology/Respiratory System</subject><subject>Pulmonary fibrosis</subject><subject>Quality of Life</subject><subject>Severity of Illness Index</subject><subject>Social Participation</subject><subject>Therapy</subject><subject>Time Factors</subject><issn>0341-2040</issn><issn>1432-1750</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1klFrFDEUhYModlv9Ab7IgCB9SU0yk2TmsRRrCytW0eeQydzspmSSdZKh7L83263aykoeAsl3LufeexB6Q8kZJUR-SIQ0pMWECty1nODtM7SgTc0wlZw8RwtSNxSzwhyh45RuCaFSUP4SHTHRCtq2fIE-X4H2eY2_gdcZhurrrL3L2yraauksVC5UNzo7CDlVdy6vq-vBxY3Oa2eqm9mPMehpW126forJpVfohdU-weuH-wT9uPz4_eIKL798ur44X2LDZZuxYZ20w0C01ANr697WlBMgAL1shGSs-IauIA0BKrQAIbrOgNQErOlL5_UJOt3X3Uzx5wwpq9ElA97rAHFOikrZ8Jp1oi3ou3_Q2zhPobi7p4oTyvhfaqU9KBdszJM2u6LqvCmeOJedKBQ-QK0gwKR9DGBdeX7Cnx3gyxlgdOag4P0jwfp-NSn6ObsY0lOQ7kFT5p4msGozubGsQlGidtlQ-2yokg21y4baFs3bh0nM_QjDH8XvMBSA7YFUvsIKpkej-m_VX_U4wPA</recordid><startdate>20160401</startdate><enddate>20160401</enddate><creator>Yount, Susan E.</creator><creator>Beaumont, Jennifer L.</creator><creator>Chen, Shih-Yin</creator><creator>Kaiser, Karen</creator><creator>Wortman, Katy</creator><creator>Van Brunt, David L.</creator><creator>Swigris, Jeffrey</creator><creator>Cella, David</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20160401</creationdate><title>Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis</title><author>Yount, Susan E. ; Beaumont, Jennifer L. ; Chen, Shih-Yin ; Kaiser, Karen ; Wortman, Katy ; Van Brunt, David L. ; Swigris, Jeffrey ; Cella, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c578t-c297fdd0a7ad283bf3150e0eeb746722034e997f40e16a6e6699ce7a0efcb1003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Care and treatment</topic><topic>Cost of Illness</topic><topic>Cough - diagnosis</topic><topic>Cough - physiopathology</topic><topic>Cough - psychology</topic><topic>Demographics</topic><topic>Development and progression</topic><topic>Dyspnea - diagnosis</topic><topic>Dyspnea - physiopathology</topic><topic>Dyspnea - psychology</topic><topic>Fatigue - diagnosis</topic><topic>Fatigue - physiopathology</topic><topic>Fatigue - psychology</topic><topic>Female</topic><topic>Health</topic><topic>Health Status</topic><topic>Humans</topic><topic>Idiopathic Pulmonary Fibrosis - diagnosis</topic><topic>Idiopathic Pulmonary Fibrosis - physiopathology</topic><topic>Idiopathic Pulmonary Fibrosis - psychology</topic><topic>Idiopathic Pulmonary Fibrosis - therapy</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Mental Health</topic><topic>Middle Aged</topic><topic>Oxygen Inhalation Therapy</topic><topic>Patient Reported Outcome Measures</topic><topic>Pneumology/Respiratory System</topic><topic>Pulmonary fibrosis</topic><topic>Quality of Life</topic><topic>Severity of Illness Index</topic><topic>Social Participation</topic><topic>Therapy</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yount, Susan E.</creatorcontrib><creatorcontrib>Beaumont, Jennifer L.</creatorcontrib><creatorcontrib>Chen, Shih-Yin</creatorcontrib><creatorcontrib>Kaiser, Karen</creatorcontrib><creatorcontrib>Wortman, Katy</creatorcontrib><creatorcontrib>Van Brunt, David L.</creatorcontrib><creatorcontrib>Swigris, Jeffrey</creatorcontrib><creatorcontrib>Cella, David</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Lung</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yount, Susan E.</au><au>Beaumont, Jennifer L.</au><au>Chen, Shih-Yin</au><au>Kaiser, Karen</au><au>Wortman, Katy</au><au>Van Brunt, David L.</au><au>Swigris, Jeffrey</au><au>Cella, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis</atitle><jtitle>Lung</jtitle><stitle>Lung</stitle><addtitle>Lung</addtitle><date>2016-04-01</date><risdate>2016</risdate><volume>194</volume><issue>2</issue><spage>227</spage><epage>234</epage><pages>227-234</pages><issn>0341-2040</issn><eissn>1432-1750</eissn><coden>LUNGD9</coden><abstract>Purpose
Idiopathic pulmonary fibrosis (IPF) produces symptoms and activity limitations that impair health-related quality of life (HRQOL). The Patient-Reported Outcomes Measurement Information System
®
(PROMIS
®
) includes measures of self-reported health and HRQOL for a range of conditions. This study evaluated the HRQOL of individuals with IPF using PROMIS measures and examined associations between HRQOL and key symptoms or supplemental oxygen need.
Methods
Individuals who reported being told by a doctor that they have IPF completed an online battery of measures at baseline and 7–10 days later (for test–retest reliability). Measures included a brief survey of demographic and health-related questions, the PROMIS-29 profile, the Modified Medical Research Council Dyspnea Scale (MMRC), PROMIS dyspnea severity short form, A Tool to Assess Quality of life in IPF (ATAQ-IPF) and one cough item from the Functional Assessment of Chronic Illness Therapy (FACIT).
Results
220 individuals were included in the final sample. Except for sleep disturbance, all PROMIS domain scores significantly (
p
< .01) differed by MMRC level. Supplemental oxygen users were more impaired than non-users in fatigue, physical function, and social role participation (
p
< 0.01). The test–retest reliability was acceptable to excellent (>0.7) for all scales, but was lower for sleep disturbance (0.64).
Conclusions
People with IPF report substantial deficits in HRQOL across a range of PROMIS domains, and deficits vary by dyspnea and cough severity. These deficits warrant monitoring in clinical practice and consideration when investigating new therapies. Further research is required to further evaluate the psychometric performance of the PROMIS-29 in IPF.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>26861885</pmid><doi>10.1007/s00408-016-9850-y</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0341-2040 |
| ispartof | Lung, 2016-04, Vol.194 (2), p.227-234 |
| issn | 0341-2040 1432-1750 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1774532968 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Aged Aged, 80 and over Care and treatment Cost of Illness Cough - diagnosis Cough - physiopathology Cough - psychology Demographics Development and progression Dyspnea - diagnosis Dyspnea - physiopathology Dyspnea - psychology Fatigue - diagnosis Fatigue - physiopathology Fatigue - psychology Female Health Health Status Humans Idiopathic Pulmonary Fibrosis - diagnosis Idiopathic Pulmonary Fibrosis - physiopathology Idiopathic Pulmonary Fibrosis - psychology Idiopathic Pulmonary Fibrosis - therapy Male Medicine Medicine & Public Health Mental Health Middle Aged Oxygen Inhalation Therapy Patient Reported Outcome Measures Pneumology/Respiratory System Pulmonary fibrosis Quality of Life Severity of Illness Index Social Participation Therapy Time Factors |
| title | Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T02%3A31%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Health-Related%20Quality%20of%20Life%20in%20Patients%20with%20Idiopathic%20Pulmonary%20Fibrosis&rft.jtitle=Lung&rft.au=Yount,%20Susan%20E.&rft.date=2016-04-01&rft.volume=194&rft.issue=2&rft.spage=227&rft.epage=234&rft.pages=227-234&rft.issn=0341-2040&rft.eissn=1432-1750&rft.coden=LUNGD9&rft_id=info:doi/10.1007/s00408-016-9850-y&rft_dat=%3Cgale_proqu%3EA446755796%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1774297125&rft_id=info:pmid/26861885&rft_galeid=A446755796&rfr_iscdi=true |